ICICI Prudential Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
3,218
-75
| -2% | -$33.4K | 0.18% | 97 |
|
|
2025
Q1 | $1.6M | Sell |
3,293
-60
| -2% | -$29.1K | 0.21% | 88 |
|
|
2024
Q4 | $1.35M | Sell |
3,353
-16
| -0.5% | -$6.44K | 0.15% | 94 |
|
|
2024
Q3 | $1.57M | Buy |
3,369
+535
| +19% | +$249K | 0.17% | 90 |
|
|
2024
Q2 | $1.33M | Buy |
2,834
+263
| +10% | +$123K | 0.16% | 93 |
|
|
2024
Q1 | $1.07M | Buy |
2,571
+70
| +3% | +$29.3K | 0.12% | 98 |
|
|
2023
Q4 | $1.02M | Buy |
2,501
+205
| +9% | +$83.4K | 0.12% | 89 |
|
|
2023
Q3 | $798K | Buy |
2,296
+545
| +31% | +$190K | 0.1% | 92 |
|
|
2023
Q2 | $616K | Buy |
1,751
+105
| +6% | +$37K | 0.08% | 98 |
|
|
2023
Q1 | $519K | Buy |
1,646
+357
| +28% | +$112K | 0.08% | 93 |
|
|
2022
Q4 | $372K | Buy |
1,289
+348
| +37% | +$100K | 0.06% | 89 |
|
|
2022
Q3 | $272K | Buy |
941
+179
| +23% | +$51.7K | 0.04% | 92 |
|
|
2022
Q2 | $214K | Buy |
762
+31
| +4% | +$8.71K | 0.04% | 95 |
|
|
2022
Q1 | $188K | Buy |
731
+104
| +17% | +$26.7K | 0.03% | 97 |
|
|
2021
Q4 | $138K | Buy |
+627
| New | +$138K | 0.02% | 100 |
|